Related Experiment Video
Updated: Nov 7, 2025

Preparation of Expanded Chitin Foams and their Use in the Removal of Aqueous Copper
Published on: February 27, 2021
Chitin and chitosan as tools to combat COVID-19: A triple approach
Mehrnoush Safarzadeh1, Sahar Sadeghi2, Mahdieh Azizi3
1Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
The progressive and fatal outbreak of the newly emerged coronavirus, SARS-CoV-2, necessitates rigorous collaboration of all health care systems and researchers from all around the world to bring such a devastating pandemic under control. As there is so far no officially approved drug or ideal vaccine for this disease, investigations on this infectious disease are actively pursued. Chitin and chitosan have shown promising results against viral infections. In this review, we first delve into the problematic consequences of viral pandemics followed by an introduction on SARS-CoV-2 taxonomical classification. Then, we elaborate on the immunology of COVID-19. Common antiviral therapies and their related limitations are described and finally, the potential applicability of chitin and chitosan to fight this overwhelming viral pandemic is addressed.
Insights
Chitin and chitosan show promise as antiviral agents against SARS-CoV-2, the virus causing COVID-19. This review explores their potential to combat the pandemic, given the lack of approved treatments.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, highlights the urgent need for effective treatments.
- Current therapeutic options for COVID-19 are limited, necessitating exploration of novel antiviral strategies.
- Chitin and chitosan are natural biopolymers with demonstrated antiviral properties.
Purpose of the Study:
- To review the immunological aspects of COVID-19.
- To discuss existing antiviral therapies and their limitations.
- To evaluate the potential of chitin and chitosan as therapeutic agents against SARS-CoV-2.
Main Methods:
- Literature review of viral pandemics, SARS-CoV-2, COVID-19 immunology, and antiviral therapies.
- Analysis of existing research on chitin and chitosan's antiviral activities.
- Exploration of chitin and chitosan's potential mechanisms of action against SARS-CoV-2.
Main Results:
- SARS-CoV-2 presents significant global health challenges.
- Existing antiviral therapies for COVID-19 have notable limitations.
- Chitin and chitosan exhibit promising broad-spectrum antiviral activities in preliminary studies.
Conclusions:
- Chitin and chitosan represent a potential novel therapeutic avenue for managing SARS-CoV-2 infections.
- Further research is warranted to elucidate the efficacy and safety of chitin and chitosan for COVID-19 treatment.
- The unique properties of chitin and chitosan may offer a valuable addition to the antiviral armamentarium.
Related Concept Videos
Chemical Agents for Microbial Control
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Hand hygiene
Hand washing...
Antimicrobial Effectiveness
Biological Methods for Microbial Control

